A detailed history of Y Intercept (Hong Kong) LTD transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 31,565 shares of COGT stock, worth $304,602. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,565
Previous 44,859 29.64%
Holding current value
$304,602
Previous $378,000 10.05%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$8.24 - $11.48 $109,542 - $152,615
-13,294 Reduced 29.64%
31,565 $340,000
Q2 2024

Aug 14, 2024

BUY
$6.01 - $9.04 $269,602 - $405,525
44,859 New
44,859 $378,000
Q4 2023

Feb 13, 2024

BUY
$4.06 - $10.08 $59,349 - $147,349
14,618 New
14,618 $85,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $635M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.